In Vitro Analysis of the Degradation of Calcium Hydroxylapatite Dermal Filler: A Proof-of-Concept Study
- 1 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 44 (1) , S5-S9
Abstract
BACKGROUND: A dissolving agent for calcium hydroxylapatite (CaHA, Radiesse) soft-tissue filler would be of value should inadvertent intravascular injection, vascular compromise, nodule formation, or overcorrection occur. METHODS: In a prospective, single-center, proof-of-concept study, 12 cadaveric porcine skin samples were injected with CaHA (0.4–0.8 mL). Samples were then randomized to intralesional injection of 0.2-mL sodium thiosulfate (STS, 12.5 g/50 mL); 1 to 2 g of topical sodium metabisulfite (SMB, 25% SMB in 120-mL gel) applied with occlusion, or both intralesional STS and topical SMB. Control samples were not treated after CaHA injection. A 4-mm punch biopsy was obtained 24 hours after treatment, and tissue sections were stained with hematoxylin and eosin and prepared for light microscopy. A board-certified dermatopathologist estimated the amount of CaHA present in each sample. RESULTS: Intralesional STS alone or combined with topical SMB completely dissolved CaHA in the porcine skin samples. Topical SMB treatment reduced, but did not entirely clear CaHA from the tissue samples. The control samples contained easily identifiable CaHA microspheres. CONCLUSION: This proof-of-concept study illustrates the potential reversibility of CaHA filler with intralesional STS, topical SMB, and the combination of both agents. Larger, in vivo, studies are now warranted to provide further insight.Keywords
This publication has 19 references indexed in Scilit:
- Intradermal sodium thiosulfate for exophytic calcinosis cutis of connective tissue diseaseJournal of the American Academy of Dermatology, 2013
- Sodium Thiosulfate Therapy for Calcific Uremic ArteriolopathyClinical Journal of the American Society of Nephrology, 2013
- Sodium thiosulfate prevents vascular calcifications in uremic ratsKidney International, 2008
- Multicenter Prospective Randomized 52-Week Trial of Calcium Hydroxylapatite Versus Bovine Dermal Collagen for Treatment of Stress Urinary IncontinenceUrology, 2007
- Vocal fold augmentation with calcium hydroxylapatite (CaHA)Otolaryngology–Head and Neck Surgery, 2007
- Evaluation of a Calcium Hydroxylapatite-Based Implant (Radiesse) for Facial Soft-Tissue AugmentationPlastic and Reconstructive Surgery, 2006
- Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite fillerJournal of Cosmetic and Laser Therapy, 2004
- Vocal Fold Augmentation with Calcium HydroxylapatiteOtolaryngology–Head and Neck Surgery, 2004
- Long-term radiographic evaluation of hydroxylapative-augmented mandibular alveolar ridgesJournal of Oral and Maxillofacial Surgery, 1984
- Kinetics of dissolution of calcium hydroxyapatiteJournal of Crystal Growth, 1983